Radiation Dose Management Market by Offering (Product: Integrated, Standalone; Services), Modality (CT, Mammography, NM), Revenue Model (Pay-Per Procedure, Annual Purchase), Application (Oncology, Cardiology, Ortho), End User - Global Forecast to 2028
The global radiation dose management market is projected to reach USD 654 million by 2028 from USD 343 million in 2023, at a CAGR of 13.8% from 2023 to 2028. The growth of the market is driven by a rising incidence of chronic diseases and growing concerns regarding radiation dose exposure. The market also benefits from a growing installed base of radiology equipment across healthcare facilities, reflecting the increasing reliance on diagnostic imaging procedures. Additionally, the surge in awareness regarding radiation dose management practices contributes to market growth. On the other hand, the lack of standardized procedures and dose protocols for radiation dose management for healthcare organizations is a major market challenge.
“Radiation dose management solutions segment to witness the highest growth during the forecast period.”
Based on product & service, the radiation dose management market is segmented into radiation dose management solutions and radiation dose management services (support & maintenance services, implementation & integration services, consulting services, and education & training services). The radiation dose management solutions segment is further sub segmented into standalone solution and integrated solutions. The integrated solution is projected to grow at the highest CAGR during the forecast period, as these solutions offer a comprehensive and streamlined approach in managing radiation doses. Moreover, the increasing complexity of healthcare systems and the integration of various technologies within medical facilities, seamless communication with diverse imaging modalities and electronic health records, real-time data exchange, enables healthcare providers to monitor and manage radiation doses more effectively. As the radiation dose management solutions continues to evolve, the integration solutions remain a cornerstone, contributing substantially to the market's growth and efficacy.
“Fluoroscopy and interventional imaging segment to register the highest growth in the radiation dose management market during the forecast period.”
Based on modality, the radiation dose management market is segmented into computed tomography (CT), fluoroscopy and interventional imaging, radiography, mammography, and nuclear medicine. The fluoroscopy and interventional imaging segment are projected to witness the highest growth in the radiation dose management market during the forecast period. The increasing demand for these procedures, is driven by a rising incidence of cardiovascular diseases and an aging population. As fluoroscopic and interventional techniques inherently involve prolonged exposure to ionizing radiation, posing potential risks to both patients and healthcare professionals; there is an increasing focus on implementing advanced radiation dose management solutions to optimize imaging protocols, monitor radiation doses in real-time, and ensure adherence to safety guidelines. Additionally technological advancements in imaging systems, increasing focus on radiation safety and regulatory compliance within the healthcare industry fuel the demand for effective radiation dose management solutions in this segment.
“APAC is estimated to register the highest CAGR during the forecast period.”
In this report, the radiation dose management market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The market in APAC is projected to register the highest growth rate during the forecast period. The growth of the market in this region is attributed to the increasing focus on interventional radiology and nuclear medicine, as well as the rising cases of cancer that demand radiation therapy. Furthermore, the increasing number of government initiatives and regulations to ensure patient safety and reduce radiation exposure is expected to drive the growth of the radiation dose management market in the APAC region.
Breakdown of supply-side primary interviews, by company type, designation, and region:
This report studies the radiation dose management market based on product & services, modality, mode of deployment, revenue model, application end user and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total radiation dose management market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report
This report also includes
“Radiation dose management solutions segment to witness the highest growth during the forecast period.”
Based on product & service, the radiation dose management market is segmented into radiation dose management solutions and radiation dose management services (support & maintenance services, implementation & integration services, consulting services, and education & training services). The radiation dose management solutions segment is further sub segmented into standalone solution and integrated solutions. The integrated solution is projected to grow at the highest CAGR during the forecast period, as these solutions offer a comprehensive and streamlined approach in managing radiation doses. Moreover, the increasing complexity of healthcare systems and the integration of various technologies within medical facilities, seamless communication with diverse imaging modalities and electronic health records, real-time data exchange, enables healthcare providers to monitor and manage radiation doses more effectively. As the radiation dose management solutions continues to evolve, the integration solutions remain a cornerstone, contributing substantially to the market's growth and efficacy.
“Fluoroscopy and interventional imaging segment to register the highest growth in the radiation dose management market during the forecast period.”
Based on modality, the radiation dose management market is segmented into computed tomography (CT), fluoroscopy and interventional imaging, radiography, mammography, and nuclear medicine. The fluoroscopy and interventional imaging segment are projected to witness the highest growth in the radiation dose management market during the forecast period. The increasing demand for these procedures, is driven by a rising incidence of cardiovascular diseases and an aging population. As fluoroscopic and interventional techniques inherently involve prolonged exposure to ionizing radiation, posing potential risks to both patients and healthcare professionals; there is an increasing focus on implementing advanced radiation dose management solutions to optimize imaging protocols, monitor radiation doses in real-time, and ensure adherence to safety guidelines. Additionally technological advancements in imaging systems, increasing focus on radiation safety and regulatory compliance within the healthcare industry fuel the demand for effective radiation dose management solutions in this segment.
“APAC is estimated to register the highest CAGR during the forecast period.”
In this report, the radiation dose management market is segmented into five major regional segments, namely, North America, Europe, Asia Pacific, Latin America and Middle East and Africa. The market in APAC is projected to register the highest growth rate during the forecast period. The growth of the market in this region is attributed to the increasing focus on interventional radiology and nuclear medicine, as well as the rising cases of cancer that demand radiation therapy. Furthermore, the increasing number of government initiatives and regulations to ensure patient safety and reduce radiation exposure is expected to drive the growth of the radiation dose management market in the APAC region.
Breakdown of supply-side primary interviews, by company type, designation, and region:
- By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
- By Designation: C-level (30%), Director-level (20%), and Others (50%)
- By Region: North America (35%), Europe (24%), Asia Pacific (25%), Latin America and Middle East Africa (16%)
- Bayer AG (Germany)
- GE Healthcare (US)
- Philips Healthcare (Netherlands)
- Siemens Healthcare (Germany)
- FUJIFILM Holdings Corporation (Japan)
- Canon Inc. (Japan)
- PACSHealth, LLC (US)
- Sectra AB (Sweden)
- Bracco Imaging S.P.A. (Italy)
- Qaelum N.V. (Belgium)
- Agfa Healthcare (Belgium)
- Novarad Corporation (US)
- Medic Vision (US)
- Guerbet (France)
- Medsquare (France)
- INFINITT Healthcare Co. Ltd. (South Korea)
- Volpara Helath Limited. (New Zealand)
- Medic Vision (Israel)
- Imalogix (US)
- Dedalus S.P.A (Italy)
- Nanjing Perlove Medical Equipment CO., LTD. (China)
- Mirion Technologies, Inc. (US)
- Landauer (US)
- Polimaster (Austria)
- Fortive (US).
This report studies the radiation dose management market based on product & services, modality, mode of deployment, revenue model, application end user and region. The report also analyses factors (such as drivers, opportunities and challenges) affecting market growth. It evaluates the opportunities and challenges in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micro markets with respect to their growth trends, prospects, and contributions to the total radiation dose management market. The report forecasts the revenue of the market segments with respect to four major regions.
Reasons to Buy the Report
This report also includes
- Analysis of key drivers (increasing use of medical imaging modalities due to growing burden of chronic diseases, growing concerns over radiation exposure, growing installation base of radiology equipment, growing awareness about radiation dose management) , challenges (lack of benchmarking for dose optimization across the globe), opportunities (growing focus on interventional radiology and nuclear medicine, radiation dose management for paediatric procedures) contributing the growth of the radiation dose management market.
- Product Development/Innovation: Detailed insights on upcoming trends, research & development activities, and new software launches in the radiation dose management market.
- Market Development: Comprehensive information on the lucrative emerging markets, product and service, mode of deployment, application, revenue model, modalities, application, end-user and region.
- Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the radiation dose management market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, company evaluation quadrant, and capabilities of leading players in the global Patient Engagement Market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKETS COVERED
1.4.2 REGIONS COVERED
1.4.3 YEARS CONSIDERED
1.4.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 RECESSION IMPACT: RADIATION DOSE MANAGEMENT MARKET
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 MARKET ESTIMATION
2.2.2 BOTTOM-UP APPROACH
FIGURE 4 BOTTOM-UP APPROACH: RADIATION DOSE MANAGEMENT MARKET
2.2.3 TOP-DOWN APPROACH
FIGURE 5 TOP-DOWN APPROACH: RADIATION DOSE MANAGEMENT MARKET
FIGURE 6 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 STUDY ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.5.1 SCOPE-RELATED LIMITATIONS
2.5.2 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: RADIATION DOSE MANAGEMENT MARKET
2.7 IMPACT OF ECONOMIC RECESSION ON RADIATION DOSE MANAGEMENT MARKET
3 EXECUTIVE SUMMARY
FIGURE 9 RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2023 VS. 2028 (USD MILLION)
FIGURE 11 RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2023 VS. 2028 (USD MILLION)
FIGURE 12 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2023 VS. 2028 (USD MILLION)
FIGURE 13 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 15 RADIATION DOSE MANAGEMENT MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 RADIATION DOSE MANAGEMENT MARKET OVERVIEW
FIGURE 16 RISING INCIDENCE OF CHRONIC DISEASES AND INCREASING CONCERNS OVER RADIATION DOSE EXPOSURE TO DRIVE MARKET
4.2 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE
FIGURE 17 SOLUTIONS COMMANDED LARGEST SHARE IN NORTH AMERICAN RADIATION DOSE MANAGEMENT MARKET IN 2022
4.3 GEOGRAPHICAL SNAPSHOT: RADIATION DOSE MANAGEMENT MARKET
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 REGIONAL MIX: RADIATION DOSE MANAGEMENT MARKET
FIGURE 19 NORTH AMERICA TO COMMAND LARGEST SHARE IN RADIATION DOSE MANAGEMENT MARKET DURING STUDY PERIOD
4.5 DEVELOPED VS. EMERGING ECONOMIES: RADIATION DOSE MANAGEMENT MARKET
FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: RADIATION DOSE MANAGEMENT MARKET
5.2.1 DRIVERS
5.2.1.1 Increasing use of medical imaging modalities
FIGURE 22 COUNT OF IMAGING ACTIVITY IN ENGLAND, ON NHS PATIENTS, MARCH 2021–MARCH 2022
TABLE 2 COUNTRY-WISE CANCER INCIDENCE, 2012–2035
5.2.1.2 Rising concerns for radiation over-exposure
5.2.1.3 Growing installation base of radiology equipment
TABLE 3 NUMBER OF CT SCANNERS, BY COUNTRY, 2020–2021 (PER 1,000,000 INHABITANTS)
TABLE 4 NUMBER OF MAMMOGRAPHY MACHINES, BY COUNTRY, 2020–2021 (PER 1,000,000 INHABITANTS)
5.2.1.4 Increasing number of radiation awareness programs and campaigns
5.2.2 RESTRAINTS
5.2.2.1 Lack of safety and protection of patient information and data
FIGURE 23 HEALTHCARE BREACHES REPORTED TO US DEPARTMENT OF HEALTH AND HUMAN SERVICES, 2021
5.2.2.2 Shortage of skilled professionals in healthcare industry
5.2.3 OPPORTUNITIES
5.2.3.1 Growing focus on interventional radiology and nuclear medicine
5.2.3.2 Increasing focus on radiation dose management for pediatric procedures
5.2.4 CHALLENGES
5.2.4.1 Lack of benchmarking for dose optimization
5.2.4.2 High installation and maintenance costs
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 INDUSTRY TRENDS
5.4.1 GROWING AWARENESS AND INCREASING NUMBER OF EDUCATIONAL INITIATIVES ON RADIATION DOSE MANAGEMENT
5.4.2 INCREASING ADOPTION OF DOSE MONITORING AND REPORTING
5.4.3 RISING USE OF IMAGE OPTIMIZATION TECHNIQUES
5.4.4 GROWING IMPORTANCE AND USE OF ARTIFICIAL INTELLIGENCE
5.5 TECHNOLOGY ANALYSIS
5.5.1 ARTIFICIAL INTELLIGENCE
5.5.2 MACHINE LEARNING
5.5.3 NEURAL NETWORKS AND DEEP LEARNING
5.6 ECOSYSTEM /MARKET MAP
FIGURE 24 ECOSYSTEM/MARKET MAP: RADIATION DOSE MANAGEMENT MARKET
5.7 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: RADIATION DOSE MANAGEMENT MARKET
5.8 TARIFF AND REGULATORY ANALYSIS
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.2 REGULATORY ANALYSIS
5.8.2.1 North America
5.8.2.1.1 US
5.8.2.1.2 Canada
5.8.2.2 Europe
5.8.2.2.1 UK
5.8.2.2.2 Spain
5.8.2.3 Asia Pacific
5.8.2.3.1 Japan
5.8.2.3.2 China
5.8.2.3.3 South Korea
5.8.2.4 Latin America
5.9 PRICING ANALYSIS
5.9.1 PRICING OVERVIEW
5.9.2 AVERAGE SELLING PRICE TREND, BY APPLICATION (KEY PLAYERS)
FIGURE 26 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
TABLE 10 AVERAGE SELLING PRICE TREND, BY APPLICATION (KEY PLAYERS)
5.9.3 INDICATIVE PRICING ANALYSIS OF RADIATION DOSE MANAGEMENT SOLUTIONS
TABLE 11 INDICATIVE PRICING ANALYSIS OF RADIATION DOSE MANAGEMENT SOLUTIONS
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 12 PORTER’S FIVE FORCES ANALYSIS: RADIATION DOSE MANAGEMENT MARKET
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF BUYERS
5.10.4 BARGAINING POWER OF SUPPLIERS
5.10.5 INTENSITY OF COMPETITIVE RIVALRY
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS FOR RADIATION DOSE MANAGEMENT
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2012–DECEMBER 2023)
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR RADIATION DOSE MANAGEMENT (JANUARY 2012–DECEMBER 2023)
FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR RADIATION DOSE MANAGEMENT PATENT DOCUMENTS
TABLE 13 LIST OF MAJOR PATENTS IN RADIATION DOSE MANAGEMENT MARKET
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RADIATION DOSE MANAGEMENT PRODUCTS/SOLUTIONS/SERVICES
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RADIATION DOSE MANAGEMENT SOLUTIONS/SERVICES
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RADIATION DOSE MANAGEMENT SOLUTIONS/SERVICES
5.12.2 BUYING CRITERIA
FIGURE 31 KEY BUYING CRITERIA FOR RADIATION DOSE MANAGEMENT SOLUTIONS
TABLE 16 KEY BUYING CRITERIA FOR RADIATION DOSE MANAGEMENT SOLUTIONS
5.13 END USER ANALYSIS
5.13.1 UNMET NEEDS
TABLE 17 UNMET NEEDS IN RADIATION DOSE MANAGEMENT MARKET
5.13.2 END USER EXPECTATIONS
TABLE 18 END USER EXPECTATIONS IN RADIATION DOSE MANAGEMENT MARKET
5.14 KEY CONFERENCES & EVENTS, 2023–2024
TABLE 19 DETAILED LIST OF KEY CONFERENCES & EVENTS, 2023–2024
5.15 INVESTMENT AND FUNDING SCENARIO
FIGURE 32 INVESTOR DEALS AND FUNDING IN RADIATION DOSE MANAGEMENT SOARED IN 2021
FIGURE 33 MOST VALUED RADIATION DOSE MANAGEMENT FIRMS IN 2022 (USD MILLION)
5.16 RADIATION DOSE MANAGEMENT REVENUE MODEL
5.16.1 SUBSCRIPTION-BASED MODELS
5.16.2 TIERED PRICING STRUCTURE
5.16.3 IMPLEMENTATION AND INTEGRATION FEES
5.16.4 CONSULTING SERVICES
5.16.5 CUSTOMIZATION FEES
5.16.6 TRAINING AND EDUCATION PROGRAMS
5.16.7 DATA ANALYTICS AND REPORTING ADD-ONS
5.16.8 TECHNICAL SUPPORT AND MAINTENANCE
5.16.9 PERFORMANCE-BASED MODELS
5.17 CASE STUDY ANALYSIS
5.17.1 FOCUS ON REDUCING RADIATION DOSE
TABLE 20 CASE STUDY 1: NEED TO MANAGE AND TRACK RADIATION DOSE IN PATIENTS
5.17.2 REDUCING RADIATION DOSE AND STREAMLINING CLINICAL OPERATIONS
TABLE 21 CASE STUDY 2: RISING NEED FOR EFFICIENT SYSTEM AND IMPROVED PATIENT CARE
5.17.3 OVERCOMING COVID-19-RELATED CHALLENGES
TABLE 22 CASE STUDY 3: ENHANCING PATIENT CARE AND INCREASING WORK-LIFE BALANCE FOR RADIOLOGISTS
6 RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 23 RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 SOLUTIONS
TABLE 24 RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 25 RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 STANDALONE SOLUTIONS
6.2.1.1 Standalone solutions to dominate radiation dose management solutions segment during forecast period
TABLE 26 STANDALONE SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 INTEGRATED SOLUTIONS
6.2.2.1 Cost-effectiveness and increased concern over radiation exposure to propel market
TABLE 27 INTEGRATED SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 SERVICES
TABLE 28 RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 29 RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 SUPPORT & MAINTENANCE SERVICES
6.3.1.1 Support & maintenance services to command largest market share during study period
TABLE 30 SUPPORT & MAINTENANCE SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 IMPLEMENTATION & INTEGRATION SERVICES
6.3.2.1 Complex healthcare ecosystem and need for seamless integration of advanced technologies to drive segment
TABLE 31 IMPLEMENTATION & INTEGRATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 CONSULTING SERVICES
6.3.3.1 Need to optimize radiation doses at healthcare facilities to support segment growth
TABLE 32 CONSULTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.4 EDUCATION & TRAINING SERVICES
6.3.4.1 Need for skill enhancement programs and hands-on knowledge of applications to drive segment
TABLE 33 EDUCATION & TRAINING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY
7.1 INTRODUCTION
TABLE 34 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
7.2 COMPUTED TOMOGRAPHY
7.2.1 INCREASING NUMBER OF COMPUTED TOMOGRAPHY EXAMINATIONS TO SUPPORT MARKET GROWTH
TABLE 35 RADIATION DOSE MANAGEMENT MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 FLUOROSCOPY & INTERVENTIONAL IMAGING
7.3.1 INCREASING NUMBER OF COMPLEX INTERVENTIONAL IMAGING PROCEDURES TO DRIVE MARKET
TABLE 36 RADIATION DOSE MANAGEMENT MARKET FOR FLUOROSCOPY & INTERVENTIONAL IMAGING, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 RADIOGRAPHY
7.4.1 LOW COST OF X-RAY IMAGING AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
TABLE 37 RADIATION DOSE MANAGEMENT MARKET FOR RADIOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 MAMMOGRAPHY
7.5.1 INCREASING INCIDENCE OF BREAST CANCER TO AID MARKET GROWTH
TABLE 38 RADIATION DOSE MANAGEMENT MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 NUCLEAR MEDICINE
7.6.1 RISING PREVALENCE OF CANCER AND CARDIOVASCULAR DISEASES TO BOOST MARKET GROWTH
TABLE 39 RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
8 RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT
8.1 INTRODUCTION
TABLE 40 RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
8.2 ON-PREMISE DEPLOYMENT
8.2.1 LIMITED COST-EFFECTIVENESS AND LOWER FLEXIBILITY TO LIMIT MARKET
TABLE 41 RADIATION DOSE MANAGEMENT MARKET FOR ON-PREMISE DEPLOYMENT, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 WEB-BASED DEPLOYMENT
8.3.1 INCREASED REQUIREMENT FOR WEB-HOSTED SUPPORT APPLICATIONS TO DRIVE MARKET
TABLE 42 RADIATION DOSE MANAGEMENT MARKET FOR WEB-BASED DEPLOYMENT, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 CLOUD-BASED DEPLOYMENT
8.4.1 EASIER ACCESSIBILITY, HIGHER SECURITY, AND GREATER PRIVACY TO DRIVE MARKET
TABLE 43 RADIATION DOSE MANAGEMENT MARKET FOR CLOUD-BASED DEPLOYMENT, BY COUNTRY, 2021–2028 (USD MILLION)
9 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL
9.1 INTRODUCTION
TABLE 44 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
9.2 CAPITAL/ANNUAL PURCHASE MODEL
9.2.1 GROWING EMPHASIS ON DATA-DRIVEN DECISION-MAKING IN HEALTHCARE TO DRIVE MARKET
TABLE 45 RADIATION DOSE MANAGEMENT MARKET FOR CAPITAL/ANNUAL PURCHASE MODEL, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 PAY-PER-PROCEDURE MODEL
9.3.1 GREATER DISCOUNTS AND EASIER PAYMENT OPTIONS TO PROPEL MARKET
TABLE 46 RADIATION DOSE MANAGEMENT MARKET FOR PAY-PER-PROCEDURE MODEL, BY COUNTRY, 2021–2028 (USD MILLION)
10 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION
10.1 INTRODUCTION
TABLE 47 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
10.2 ONCOLOGY
10.2.1 LIMITED COMPLICATIONS AND LESSER NUMBER OF SIDE EFFECTS TO HEALTHY TISSUES TO DRIVE MARKET
TABLE 48 US: RADIATION-TREATED CANCER SURVIVORS, 2016–2030 (THOUSAND)
TABLE 49 RADIATION DOSE MANAGEMENT MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 CARDIOLOGY
10.3.1 RISING USE OF IMAGING TECHNIQUES IN CARDIOVASCULAR INTERVENTIONS TO PROPEL MARKET
TABLE 50 RADIATION DOSE MANAGEMENT MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
10.4 DENTAL
10.4.1 GROWING RELIANCE ON DIAGNOSTIC IMAGING TECHNIQUES IN DENTISTRY TO SUPPORT MARKET GROWTH
TABLE 51 RADIATION DOSE MANAGEMENT MARKET FOR DENTAL, BY COUNTRY, 2021–2028 (USD MILLION)
10.5 ORTHOPEDIC
10.5.1 INCREASING NUMBER OF ORTHOPEDIC PROCEDURES AND RISING GERIATRIC POPULATION TO PROPEL MARKET
TABLE 52 RADIATION DOSE MANAGEMENT MARKET FOR ORTHOPEDIC, BY COUNTRY, 2021–2028 (USD MILLION)
10.6 OTHER APPLICATIONS
TABLE 53 RADIATION DOSE MANAGEMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
11 RADIATION DOSE MANAGEMENT MARKET, BY END USER
11.1 INTRODUCTION
TABLE 54 RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2 HOSPITALS AND HEALTHCARE SYSTEMS
11.2.1 RISING ADOPTION OF ADVANCED DIAGNOSTIC IMAGING SYSTEMS TO DRIVE MARKET
TABLE 55 RADIATION DOSE MANAGEMENT MARKET FOR HOSPITALS AND HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
11.3 AMBULATORY SURGERY CENTERS
11.3.1 INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT MARKET GROWTH
TABLE 56 RADIATION DOSE MANAGEMENT MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
11.4 DIAGNOSTIC AND IMAGING CENTERS
11.4.1 RISING NUMBER OF PRIVATE IMAGING CENTERS AND GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
TABLE 57 RADIATION DOSE MANAGEMENT MARKET FOR DIAGNOSTIC AND IMAGING CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
11.5 OTHER END USERS
TABLE 58 RADIATION DOSE MANAGEMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
12 RADIATION DOSE MANAGEMENT MARKET, BY REGION
12.1 INTRODUCTION
TABLE 59 RADIATION DOSE MANAGEMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
12.2 NORTH AMERICA
FIGURE 34 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET SNAPSHOT
TABLE 60 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 62 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 66 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 67 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 68 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.2.1 NORTH AMERICA: RECESSION IMPACT
12.2.2 US
12.2.2.1 US to command largest share of North American radiation dose management market during forecast period
TABLE 69 US: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 70 US: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 71 US: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 72 US: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 73 US: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 74 US: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 75 US: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 76 US: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.2.3 CANADA
12.2.3.1 Increasing number of radiography procedures to drive market
TABLE 77 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 78 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 79 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 80 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 81 CANADA: RADIATION DOSE MANAGEMENT MARKET SIZE, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 82 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 83 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 84 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3 EUROPE
TABLE 85 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 87 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 88 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 89 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 90 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 91 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 92 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 93 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.1 EUROPE: RECESSION IMPACT
12.3.2 FRANCE
12.3.2.1 Rising number of CT procedures in children to propel market
TABLE 94 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 95 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 96 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 97 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 98 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 99 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 100 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 101 RANCE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.3 GERMANY
12.3.3.1 Increasing number of radiography procedures and improving healthcare system to support market growth
TABLE 102 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 103 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 106 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 107 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 108 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 109 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.4 UK
12.3.4.1 Increasing number of diagnostic imaging modalities and interventional procedures to drive market
TABLE 110 UK: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 111 UK: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 112 UK: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 UK: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 114 UK: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 115 UK: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 116 UK: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 117 UK: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.5 ITALY
12.3.5.1 Increased government focus on implementing eHealth technologies and stringent EU directives to fuel market growth
TABLE 118 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 119 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 122 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 123 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 124 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 125 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.6 SPAIN
12.3.6.1 Increasing prevalence of cancer to propel market
TABLE 126 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 127 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 129 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 130 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 131 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 132 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 133 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.7 REST OF EUROPE
TABLE 134 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 135 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 138 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 139 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 140 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 141 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET SNAPSHOT
TABLE 142 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 144 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 147 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 148 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 149 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 150 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.1 ASIA PACIFIC: RECESSION IMPACT
12.4.2 JAPAN
12.4.2.1 Increasing prevalence of cancer and growing geriatric population to fuel market growth
TABLE 151 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 152 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 153 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 154 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 155 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 156 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 157 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 158 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.3 CHINA
12.4.3.1 Large patient pool and increased healthcare spending to aid market growth
TABLE 159 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 160 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 163 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 164 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 165 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 166 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.4 INDIA
12.4.4.1 Favorable government policies and improved healthcare infrastructure to support market growth
TABLE 167 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 168 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 171 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 172 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 173 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 174 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.5 REST OF ASIA PACIFIC
TABLE 175 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 176 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 179 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 180 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 181 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 182 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 200 "12.5 LATIN AMERICATABLE 183 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 184 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 185 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 188 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 189 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 190 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 191 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.1 LATIN AMERICA: RECESSION IMPACT
12.5.2 BRAZIL
12.5.2.1 Growing emphasis on reducing healthcare costs and increasing government focus on rural healthcare to drive market
TABLE 192 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 193 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 194 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 195 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 196 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 197 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 198 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 199 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.3 MEXICO
12.5.3.1 Increasing demand and adoption of healthcare IT solutions to drive market
TABLE 200 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 201 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 202 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 203 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 204 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 205 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 206 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 207 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.4 REST OF LATIN AMERICA
TABLE 208 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 209 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 210 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 211 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 212 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 213 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 214 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 215 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.6 MIDDLE EAST & AFRICA
TABLE 216 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 223 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 224 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
12.6.2 GCC COUNTRIES
12.6.2.1 Initiatives for improving health infrastructure to propel market
TABLE 225 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 226 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 227 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 228 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 229 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 230 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 231 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 232 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.6.3 REST OF MIDDLE EAST & AFRICA
TABLE 233 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 234 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 236 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 237 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 238 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 239 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 240 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 241 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIATION DOSE MANAGEMENT MARKET
13.3 REVENUE SHARE ANALYSIS
FIGURE 36 REVENUE SHARE ANALYSIS, 2018–2022
13.4 MARKET SHARE ANALYSIS
FIGURE 37 MARKET SHARE ANALYSIS, 2022
TABLE 242 DEGREE OF COMPETITION: RADIATION DOSE MANAGEMENT MARKET
FIGURE 38 RANKING OF KEY COMPANIES IN RADIATION DOSE MANAGEMENT MARKET, 2022
13.5 BRAND/SOFTWARE COMPARISON
FIGURE 39 TOP TRENDING BRANDS/SOFTWARE IN RADIATION DOSE MANAGEMENT MARKET
FIGURE 40 BRAND/SOFTWARE COMPARISON: RADIATION DOSE MANAGEMENT MARKET
13.5.1 BAYER AG.
13.5.2 GE HEALTHCARE
13.5.3 PACSHEALTH, LLC
13.5.4 VOLPARA HEALTH LIMITED
13.5.5 BRACCO
13.6 COMPANY VALUATION AND FINANCIAL METRICS
13.7 COMPANY EVALUATION MATRIX
13.7.1 STARS
13.7.2 EMERGING LEADERS
13.7.3 PERVASIVE PLAYERS
13.7.4 PARTICIPANTS
FIGURE 41 COMPANY EVALUATION MATRIX, 2022
13.7.5 COMPANY FOOTPRINT
TABLE 243 OVERALL FOOTPRINT
TABLE 244 PRODUCT & SERVICE FOOTPRINT
TABLE 245 MODALITY FOOTPRINT
TABLE 246 REGIONAL FOOTPRINT
13.8 START-UP/SME EVALUATION MATRIX
13.8.1 PROGRESSIVE COMPANIES
13.8.2 RESPONSIVE COMPANIES
13.8.3 DYNAMIC COMPANIES
13.8.4 STARTING BLOCKS
FIGURE 42 START-UP/SME EVALUATION MATRIX, 2022
13.8.5 COMPETITIVE BENCHMARKING
TABLE 247 DETAILED LIST OF KEY START-UPS/SMES
TABLE 248 COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES
TABLE 249 RADIATION DOSE MANAGEMENT MARKET: PRODUCT LAUNCHES, 2020–2023
13.9.2 DEALS
TABLE 250 RADIATION DOSE MANAGEMENT MARKET: DEALS, 2020–2023
14 COMPANY PROFILES
(Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1 KEY PLAYERS
14.1.1 BAYER AG
TABLE 251 BAYER AG: COMPANY OVERVIEW
FIGURE 43 BAYER AG: COMPANY SNAPSHOT (2022)
TABLE 252 BAYER AG: PRODUCT LAUNCHES
14.1.2 GE HEALTHCARE
TABLE 253 GE HEALTHCARE: COMPANY OVERVIEW
FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
14.1.3 KONINKLIJKE PHILIPS N.V.
TABLE 254 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
FIGURE 45 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
14.1.4 SECTRA AB
TABLE 255 SECTRA AB: COMPANY OVERVIEW
FIGURE 46 SECTRA AB: COMPANY SNAPSHOT (2022)
14.1.5 AGFA-GEVAERT GROUP
TABLE 256 AGFA-GEVAERT GROUP: COMPANY OVERVIEW
FIGURE 47 AGFA-GEVAERT GROUP.: COMPANY SNAPSHOT (2022)
TABLE 257 AGFA-GEVAERT GROUP: OTHER DEVELOPMENTS
14.1.6 SIEMENS HEALTHCARE PRIVATE LIMITED
TABLE 258 SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY OVERVIEW
FIGURE 48 SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY SNAPSHOT (2022)
TABLE 259 SIEMENS HEALTHCARE PRIVATE LIMITED: PRODUCT LAUNCHES
14.1.7 CANON MEDICAL SYSTEMS CORPORATION
TABLE 260 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
FIGURE 49 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2022)
14.1.8 PACSHEALTH, LLC
TABLE 261 PACSHEALTH, LLC: COMPANY OVERVIEW
14.1.9 NOVARAD CORPORATION
TABLE 262 NOVARAD CORPORATION: COMPANY OVERVIEW
14.1.10 QAELUM N.V.
TABLE 263 QAELUM N.V.: COMPANY OVERVIEW
TABLE 264 QAELUM N.V.: DEALS
14.1.11 BRACCO
TABLE 265 BRACCO: COMPANY OVERVIEW
14.1.12 GUERBET
TABLE 266 GUERBET: COMPANY OVERVIEW
FIGURE 50 GUERBET: COMPANY SNAPSHOT (2022)
14.1.13 FUJIFILM HOLDINGS CORPORATION
TABLE 267 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
FIGURE 51 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 268 FUJIFILM HOLDINGS CORPORATION: DEALS
14.1.14 INFINITT HEALTHCARE CO., LTD.
TABLE 269 INFINITT HEALTHCARE CO., LTD.: COMPANY OVERVIEW
14.1.15 MEDSQUARE
TABLE 270 MEDSQUARE: COMPANY OVERVIEW
14.1.16 MEDIC VISION
TABLE 271 MEDIC VISION: COMPANY OVERVIEW
14.1.17 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.
TABLE 272 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: COMPANY OVERVIEW
14.1.18 VOLPARA HEALTH LIMITED.
TABLE 273 VOLPARA HEALTH LIMITED: COMPANY OVERVIEW
FIGURE 52 VOLPARA HEALTH LIMITED: COMPANY SNAPSHOT (2022)
TABLE 274 VOLPARA HEALTH LIMITED: DEALS
14.1.19 MIRION TECHNOLOGIES, INC.
TABLE 275 MIRION TECHNOLOGIES, INC.: COMPANY OVERVIEW
14.2 OTHER PLAYERS
14.2.1 IMALOGIX
14.2.2 LANDAUER
14.2.3 RAYSEARCH LABORATORIES
14.2.4 I-SOLUTIONS HEALTH GMBH
14.2.5 MEDIGRATION
14.2.6 TECNOLOGIE AVANZATE
*Details on Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
5 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.3 INCLUSIONS & EXCLUSIONS
1.4 MARKET SCOPE
1.4.1 MARKETS COVERED
1.4.2 REGIONS COVERED
1.4.3 YEARS CONSIDERED
1.4.4 CURRENCY CONSIDERED
1.5 STAKEHOLDERS
1.6 SUMMARY OF CHANGES
1.6.1 RECESSION IMPACT: RADIATION DOSE MANAGEMENT MARKET
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.1.1 Key data from secondary sources
2.1.2 PRIMARY DATA
2.1.2.1 Primary sources
2.1.2.2 Key data from primary sources
2.1.2.3 Key industry insights
FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
2.2 MARKET SIZE ESTIMATION
FIGURE 3 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
2.2.1 MARKET ESTIMATION
2.2.2 BOTTOM-UP APPROACH
FIGURE 4 BOTTOM-UP APPROACH: RADIATION DOSE MANAGEMENT MARKET
2.2.3 TOP-DOWN APPROACH
FIGURE 5 TOP-DOWN APPROACH: RADIATION DOSE MANAGEMENT MARKET
FIGURE 6 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028)
FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 8 DATA TRIANGULATION METHODOLOGY
2.4 STUDY ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.5.1 SCOPE-RELATED LIMITATIONS
2.5.2 METHODOLOGY-RELATED LIMITATIONS
2.6 RISK ASSESSMENT
TABLE 1 RISK ASSESSMENT: RADIATION DOSE MANAGEMENT MARKET
2.7 IMPACT OF ECONOMIC RECESSION ON RADIATION DOSE MANAGEMENT MARKET
3 EXECUTIVE SUMMARY
FIGURE 9 RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 10 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2023 VS. 2028 (USD MILLION)
FIGURE 11 RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2023 VS. 2028 (USD MILLION)
FIGURE 12 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2023 VS. 2028 (USD MILLION)
FIGURE 13 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2023 VS. 2028 (USD MILLION)
FIGURE 14 RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 15 RADIATION DOSE MANAGEMENT MARKET, BY REGION, 2023 VS. 2028 (USD MILLION)
4 PREMIUM INSIGHTS
4.1 RADIATION DOSE MANAGEMENT MARKET OVERVIEW
FIGURE 16 RISING INCIDENCE OF CHRONIC DISEASES AND INCREASING CONCERNS OVER RADIATION DOSE EXPOSURE TO DRIVE MARKET
4.2 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE
FIGURE 17 SOLUTIONS COMMANDED LARGEST SHARE IN NORTH AMERICAN RADIATION DOSE MANAGEMENT MARKET IN 2022
4.3 GEOGRAPHICAL SNAPSHOT: RADIATION DOSE MANAGEMENT MARKET
FIGURE 18 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
4.4 REGIONAL MIX: RADIATION DOSE MANAGEMENT MARKET
FIGURE 19 NORTH AMERICA TO COMMAND LARGEST SHARE IN RADIATION DOSE MANAGEMENT MARKET DURING STUDY PERIOD
4.5 DEVELOPED VS. EMERGING ECONOMIES: RADIATION DOSE MANAGEMENT MARKET
FIGURE 20 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 21 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES: RADIATION DOSE MANAGEMENT MARKET
5.2.1 DRIVERS
5.2.1.1 Increasing use of medical imaging modalities
FIGURE 22 COUNT OF IMAGING ACTIVITY IN ENGLAND, ON NHS PATIENTS, MARCH 2021–MARCH 2022
TABLE 2 COUNTRY-WISE CANCER INCIDENCE, 2012–2035
5.2.1.2 Rising concerns for radiation over-exposure
5.2.1.3 Growing installation base of radiology equipment
TABLE 3 NUMBER OF CT SCANNERS, BY COUNTRY, 2020–2021 (PER 1,000,000 INHABITANTS)
TABLE 4 NUMBER OF MAMMOGRAPHY MACHINES, BY COUNTRY, 2020–2021 (PER 1,000,000 INHABITANTS)
5.2.1.4 Increasing number of radiation awareness programs and campaigns
5.2.2 RESTRAINTS
5.2.2.1 Lack of safety and protection of patient information and data
FIGURE 23 HEALTHCARE BREACHES REPORTED TO US DEPARTMENT OF HEALTH AND HUMAN SERVICES, 2021
5.2.2.2 Shortage of skilled professionals in healthcare industry
5.2.3 OPPORTUNITIES
5.2.3.1 Growing focus on interventional radiology and nuclear medicine
5.2.3.2 Increasing focus on radiation dose management for pediatric procedures
5.2.4 CHALLENGES
5.2.4.1 Lack of benchmarking for dose optimization
5.2.4.2 High installation and maintenance costs
5.3 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.4 INDUSTRY TRENDS
5.4.1 GROWING AWARENESS AND INCREASING NUMBER OF EDUCATIONAL INITIATIVES ON RADIATION DOSE MANAGEMENT
5.4.2 INCREASING ADOPTION OF DOSE MONITORING AND REPORTING
5.4.3 RISING USE OF IMAGE OPTIMIZATION TECHNIQUES
5.4.4 GROWING IMPORTANCE AND USE OF ARTIFICIAL INTELLIGENCE
5.5 TECHNOLOGY ANALYSIS
5.5.1 ARTIFICIAL INTELLIGENCE
5.5.2 MACHINE LEARNING
5.5.3 NEURAL NETWORKS AND DEEP LEARNING
5.6 ECOSYSTEM /MARKET MAP
FIGURE 24 ECOSYSTEM/MARKET MAP: RADIATION DOSE MANAGEMENT MARKET
5.7 VALUE CHAIN ANALYSIS
FIGURE 25 VALUE CHAIN ANALYSIS: RADIATION DOSE MANAGEMENT MARKET
5.8 TARIFF AND REGULATORY ANALYSIS
5.8.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 8 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 9 MIDDLE EAST & AFRICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.8.2 REGULATORY ANALYSIS
5.8.2.1 North America
5.8.2.1.1 US
5.8.2.1.2 Canada
5.8.2.2 Europe
5.8.2.2.1 UK
5.8.2.2.2 Spain
5.8.2.3 Asia Pacific
5.8.2.3.1 Japan
5.8.2.3.2 China
5.8.2.3.3 South Korea
5.8.2.4 Latin America
5.9 PRICING ANALYSIS
5.9.1 PRICING OVERVIEW
5.9.2 AVERAGE SELLING PRICE TREND, BY APPLICATION (KEY PLAYERS)
FIGURE 26 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY APPLICATION
TABLE 10 AVERAGE SELLING PRICE TREND, BY APPLICATION (KEY PLAYERS)
5.9.3 INDICATIVE PRICING ANALYSIS OF RADIATION DOSE MANAGEMENT SOLUTIONS
TABLE 11 INDICATIVE PRICING ANALYSIS OF RADIATION DOSE MANAGEMENT SOLUTIONS
5.10 PORTER’S FIVE FORCES ANALYSIS
TABLE 12 PORTER’S FIVE FORCES ANALYSIS: RADIATION DOSE MANAGEMENT MARKET
5.10.1 THREAT OF NEW ENTRANTS
5.10.2 THREAT OF SUBSTITUTES
5.10.3 BARGAINING POWER OF BUYERS
5.10.4 BARGAINING POWER OF SUPPLIERS
5.10.5 INTENSITY OF COMPETITIVE RIVALRY
5.11 PATENT ANALYSIS
5.11.1 PATENT PUBLICATION TRENDS FOR RADIATION DOSE MANAGEMENT
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2012–DECEMBER 2023)
5.11.2 INSIGHTS: JURISDICTION AND TOP APPLICANT ANALYSIS
FIGURE 28 TOP APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR RADIATION DOSE MANAGEMENT (JANUARY 2012–DECEMBER 2023)
FIGURE 29 TOP APPLICANT COUNTRIES/REGIONS FOR RADIATION DOSE MANAGEMENT PATENT DOCUMENTS
TABLE 13 LIST OF MAJOR PATENTS IN RADIATION DOSE MANAGEMENT MARKET
5.12 KEY STAKEHOLDERS & BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
TABLE 14 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RADIATION DOSE MANAGEMENT PRODUCTS/SOLUTIONS/SERVICES
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RADIATION DOSE MANAGEMENT SOLUTIONS/SERVICES
TABLE 15 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RADIATION DOSE MANAGEMENT SOLUTIONS/SERVICES
5.12.2 BUYING CRITERIA
FIGURE 31 KEY BUYING CRITERIA FOR RADIATION DOSE MANAGEMENT SOLUTIONS
TABLE 16 KEY BUYING CRITERIA FOR RADIATION DOSE MANAGEMENT SOLUTIONS
5.13 END USER ANALYSIS
5.13.1 UNMET NEEDS
TABLE 17 UNMET NEEDS IN RADIATION DOSE MANAGEMENT MARKET
5.13.2 END USER EXPECTATIONS
TABLE 18 END USER EXPECTATIONS IN RADIATION DOSE MANAGEMENT MARKET
5.14 KEY CONFERENCES & EVENTS, 2023–2024
TABLE 19 DETAILED LIST OF KEY CONFERENCES & EVENTS, 2023–2024
5.15 INVESTMENT AND FUNDING SCENARIO
FIGURE 32 INVESTOR DEALS AND FUNDING IN RADIATION DOSE MANAGEMENT SOARED IN 2021
FIGURE 33 MOST VALUED RADIATION DOSE MANAGEMENT FIRMS IN 2022 (USD MILLION)
5.16 RADIATION DOSE MANAGEMENT REVENUE MODEL
5.16.1 SUBSCRIPTION-BASED MODELS
5.16.2 TIERED PRICING STRUCTURE
5.16.3 IMPLEMENTATION AND INTEGRATION FEES
5.16.4 CONSULTING SERVICES
5.16.5 CUSTOMIZATION FEES
5.16.6 TRAINING AND EDUCATION PROGRAMS
5.16.7 DATA ANALYTICS AND REPORTING ADD-ONS
5.16.8 TECHNICAL SUPPORT AND MAINTENANCE
5.16.9 PERFORMANCE-BASED MODELS
5.17 CASE STUDY ANALYSIS
5.17.1 FOCUS ON REDUCING RADIATION DOSE
TABLE 20 CASE STUDY 1: NEED TO MANAGE AND TRACK RADIATION DOSE IN PATIENTS
5.17.2 REDUCING RADIATION DOSE AND STREAMLINING CLINICAL OPERATIONS
TABLE 21 CASE STUDY 2: RISING NEED FOR EFFICIENT SYSTEM AND IMPROVED PATIENT CARE
5.17.3 OVERCOMING COVID-19-RELATED CHALLENGES
TABLE 22 CASE STUDY 3: ENHANCING PATIENT CARE AND INCREASING WORK-LIFE BALANCE FOR RADIOLOGISTS
6 RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 23 RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 SOLUTIONS
TABLE 24 RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 25 RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 STANDALONE SOLUTIONS
6.2.1.1 Standalone solutions to dominate radiation dose management solutions segment during forecast period
TABLE 26 STANDALONE SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 INTEGRATED SOLUTIONS
6.2.2.1 Cost-effectiveness and increased concern over radiation exposure to propel market
TABLE 27 INTEGRATED SOLUTIONS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 SERVICES
TABLE 28 RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 29 RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 SUPPORT & MAINTENANCE SERVICES
6.3.1.1 Support & maintenance services to command largest market share during study period
TABLE 30 SUPPORT & MAINTENANCE SERVICES, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 IMPLEMENTATION & INTEGRATION SERVICES
6.3.2.1 Complex healthcare ecosystem and need for seamless integration of advanced technologies to drive segment
TABLE 31 IMPLEMENTATION & INTEGRATION SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 CONSULTING SERVICES
6.3.3.1 Need to optimize radiation doses at healthcare facilities to support segment growth
TABLE 32 CONSULTING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.4 EDUCATION & TRAINING SERVICES
6.3.4.1 Need for skill enhancement programs and hands-on knowledge of applications to drive segment
TABLE 33 EDUCATION & TRAINING SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY
7.1 INTRODUCTION
TABLE 34 RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
7.2 COMPUTED TOMOGRAPHY
7.2.1 INCREASING NUMBER OF COMPUTED TOMOGRAPHY EXAMINATIONS TO SUPPORT MARKET GROWTH
TABLE 35 RADIATION DOSE MANAGEMENT MARKET FOR COMPUTED TOMOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 FLUOROSCOPY & INTERVENTIONAL IMAGING
7.3.1 INCREASING NUMBER OF COMPLEX INTERVENTIONAL IMAGING PROCEDURES TO DRIVE MARKET
TABLE 36 RADIATION DOSE MANAGEMENT MARKET FOR FLUOROSCOPY & INTERVENTIONAL IMAGING, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 RADIOGRAPHY
7.4.1 LOW COST OF X-RAY IMAGING AND TECHNOLOGICAL ADVANCEMENTS TO DRIVE MARKET
TABLE 37 RADIATION DOSE MANAGEMENT MARKET FOR RADIOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
7.5 MAMMOGRAPHY
7.5.1 INCREASING INCIDENCE OF BREAST CANCER TO AID MARKET GROWTH
TABLE 38 RADIATION DOSE MANAGEMENT MARKET FOR MAMMOGRAPHY, BY COUNTRY, 2021–2028 (USD MILLION)
7.6 NUCLEAR MEDICINE
7.6.1 RISING PREVALENCE OF CANCER AND CARDIOVASCULAR DISEASES TO BOOST MARKET GROWTH
TABLE 39 RADIATION DOSE MANAGEMENT MARKET FOR NUCLEAR MEDICINE, BY COUNTRY, 2021–2028 (USD MILLION)
8 RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT
8.1 INTRODUCTION
TABLE 40 RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
8.2 ON-PREMISE DEPLOYMENT
8.2.1 LIMITED COST-EFFECTIVENESS AND LOWER FLEXIBILITY TO LIMIT MARKET
TABLE 41 RADIATION DOSE MANAGEMENT MARKET FOR ON-PREMISE DEPLOYMENT, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 WEB-BASED DEPLOYMENT
8.3.1 INCREASED REQUIREMENT FOR WEB-HOSTED SUPPORT APPLICATIONS TO DRIVE MARKET
TABLE 42 RADIATION DOSE MANAGEMENT MARKET FOR WEB-BASED DEPLOYMENT, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 CLOUD-BASED DEPLOYMENT
8.4.1 EASIER ACCESSIBILITY, HIGHER SECURITY, AND GREATER PRIVACY TO DRIVE MARKET
TABLE 43 RADIATION DOSE MANAGEMENT MARKET FOR CLOUD-BASED DEPLOYMENT, BY COUNTRY, 2021–2028 (USD MILLION)
9 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL
9.1 INTRODUCTION
TABLE 44 RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
9.2 CAPITAL/ANNUAL PURCHASE MODEL
9.2.1 GROWING EMPHASIS ON DATA-DRIVEN DECISION-MAKING IN HEALTHCARE TO DRIVE MARKET
TABLE 45 RADIATION DOSE MANAGEMENT MARKET FOR CAPITAL/ANNUAL PURCHASE MODEL, BY COUNTRY, 2021–2028 (USD MILLION)
9.3 PAY-PER-PROCEDURE MODEL
9.3.1 GREATER DISCOUNTS AND EASIER PAYMENT OPTIONS TO PROPEL MARKET
TABLE 46 RADIATION DOSE MANAGEMENT MARKET FOR PAY-PER-PROCEDURE MODEL, BY COUNTRY, 2021–2028 (USD MILLION)
10 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION
10.1 INTRODUCTION
TABLE 47 RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
10.2 ONCOLOGY
10.2.1 LIMITED COMPLICATIONS AND LESSER NUMBER OF SIDE EFFECTS TO HEALTHY TISSUES TO DRIVE MARKET
TABLE 48 US: RADIATION-TREATED CANCER SURVIVORS, 2016–2030 (THOUSAND)
TABLE 49 RADIATION DOSE MANAGEMENT MARKET FOR ONCOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
10.3 CARDIOLOGY
10.3.1 RISING USE OF IMAGING TECHNIQUES IN CARDIOVASCULAR INTERVENTIONS TO PROPEL MARKET
TABLE 50 RADIATION DOSE MANAGEMENT MARKET FOR CARDIOLOGY, BY COUNTRY, 2021–2028 (USD MILLION)
10.4 DENTAL
10.4.1 GROWING RELIANCE ON DIAGNOSTIC IMAGING TECHNIQUES IN DENTISTRY TO SUPPORT MARKET GROWTH
TABLE 51 RADIATION DOSE MANAGEMENT MARKET FOR DENTAL, BY COUNTRY, 2021–2028 (USD MILLION)
10.5 ORTHOPEDIC
10.5.1 INCREASING NUMBER OF ORTHOPEDIC PROCEDURES AND RISING GERIATRIC POPULATION TO PROPEL MARKET
TABLE 52 RADIATION DOSE MANAGEMENT MARKET FOR ORTHOPEDIC, BY COUNTRY, 2021–2028 (USD MILLION)
10.6 OTHER APPLICATIONS
TABLE 53 RADIATION DOSE MANAGEMENT MARKET FOR OTHER APPLICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)
11 RADIATION DOSE MANAGEMENT MARKET, BY END USER
11.1 INTRODUCTION
TABLE 54 RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
11.2 HOSPITALS AND HEALTHCARE SYSTEMS
11.2.1 RISING ADOPTION OF ADVANCED DIAGNOSTIC IMAGING SYSTEMS TO DRIVE MARKET
TABLE 55 RADIATION DOSE MANAGEMENT MARKET FOR HOSPITALS AND HEALTHCARE SYSTEMS, BY COUNTRY, 2021–2028 (USD MILLION)
11.3 AMBULATORY SURGERY CENTERS
11.3.1 INCREASING NUMBER OF INTERVENTIONAL IMAGING PROCEDURES TO SUPPORT MARKET GROWTH
TABLE 56 RADIATION DOSE MANAGEMENT MARKET FOR AMBULATORY SURGERY CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
11.4 DIAGNOSTIC AND IMAGING CENTERS
11.4.1 RISING NUMBER OF PRIVATE IMAGING CENTERS AND GROWING PREVALENCE OF CHRONIC DISEASES TO DRIVE MARKET
TABLE 57 RADIATION DOSE MANAGEMENT MARKET FOR DIAGNOSTIC AND IMAGING CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)
11.5 OTHER END USERS
TABLE 58 RADIATION DOSE MANAGEMENT MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)
12 RADIATION DOSE MANAGEMENT MARKET, BY REGION
12.1 INTRODUCTION
TABLE 59 RADIATION DOSE MANAGEMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
12.2 NORTH AMERICA
FIGURE 34 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET SNAPSHOT
TABLE 60 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 62 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 63 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 64 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 66 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 67 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 68 NORTH AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.2.1 NORTH AMERICA: RECESSION IMPACT
12.2.2 US
12.2.2.1 US to command largest share of North American radiation dose management market during forecast period
TABLE 69 US: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 70 US: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 71 US: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 72 US: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 73 US: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 74 US: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 75 US: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 76 US: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.2.3 CANADA
12.2.3.1 Increasing number of radiography procedures to drive market
TABLE 77 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 78 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 79 CANADA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 80 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 81 CANADA: RADIATION DOSE MANAGEMENT MARKET SIZE, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 82 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 83 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 84 CANADA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3 EUROPE
TABLE 85 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 86 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 87 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 88 EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 89 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 90 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 91 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 92 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 93 EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.1 EUROPE: RECESSION IMPACT
12.3.2 FRANCE
12.3.2.1 Rising number of CT procedures in children to propel market
TABLE 94 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 95 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 96 FRANCE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 97 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 98 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 99 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 100 FRANCE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 101 RANCE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.3 GERMANY
12.3.3.1 Increasing number of radiography procedures and improving healthcare system to support market growth
TABLE 102 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 103 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 104 GERMANY: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 105 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 106 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 107 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 108 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 109 GERMANY: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.4 UK
12.3.4.1 Increasing number of diagnostic imaging modalities and interventional procedures to drive market
TABLE 110 UK: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 111 UK: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 112 UK: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 113 UK: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 114 UK: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 115 UK: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 116 UK: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 117 UK: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.5 ITALY
12.3.5.1 Increased government focus on implementing eHealth technologies and stringent EU directives to fuel market growth
TABLE 118 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 119 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 ITALY: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 122 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 123 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 124 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 125 ITALY: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.6 SPAIN
12.3.6.1 Increasing prevalence of cancer to propel market
TABLE 126 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 127 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 128 SPAIN: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 129 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 130 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 131 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 132 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 133 SPAIN: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.3.7 REST OF EUROPE
TABLE 134 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 135 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 138 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 139 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 140 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 141 REST OF EUROPE: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4 ASIA PACIFIC
FIGURE 35 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET SNAPSHOT
TABLE 142 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 143 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 144 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 145 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 147 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 148 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 149 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 150 ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.1 ASIA PACIFIC: RECESSION IMPACT
12.4.2 JAPAN
12.4.2.1 Increasing prevalence of cancer and growing geriatric population to fuel market growth
TABLE 151 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 152 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 153 JAPAN: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 154 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 155 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 156 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 157 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 158 JAPAN: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.3 CHINA
12.4.3.1 Large patient pool and increased healthcare spending to aid market growth
TABLE 159 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 160 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 161 CHINA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 163 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 164 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 165 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 166 CHINA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.4 INDIA
12.4.4.1 Favorable government policies and improved healthcare infrastructure to support market growth
TABLE 167 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 168 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 169 INDIA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 170 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 171 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 172 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 173 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 174 INDIA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.4.5 REST OF ASIA PACIFIC
TABLE 175 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 176 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 179 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 180 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 181 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 182 REST OF ASIA PACIFIC: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION) 200 "12.5 LATIN AMERICATABLE 183 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 184 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 185 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 186 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 188 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 189 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 190 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 191 LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.1 LATIN AMERICA: RECESSION IMPACT
12.5.2 BRAZIL
12.5.2.1 Growing emphasis on reducing healthcare costs and increasing government focus on rural healthcare to drive market
TABLE 192 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 193 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 194 BRAZIL: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 195 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 196 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 197 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 198 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 199 BRAZIL: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.3 MEXICO
12.5.3.1 Increasing demand and adoption of healthcare IT solutions to drive market
TABLE 200 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 201 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 202 MEXICO: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 203 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 204 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 205 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 206 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 207 MEXICO: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.5.4 REST OF LATIN AMERICA
TABLE 208 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 209 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 210 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 211 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 212 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 213 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 214 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 215 REST OF LATIN AMERICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.6 MIDDLE EAST & AFRICA
TABLE 216 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 218 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 219 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 220 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 221 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 222 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 223 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 224 MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
12.6.2 GCC COUNTRIES
12.6.2.1 Initiatives for improving health infrastructure to propel market
TABLE 225 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 226 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET FOR SOLUTIONS, BY TYPE, 2021–2028 (USD MILLION)
TABLE 227 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 228 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 229 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 230 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 231 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 232 GCC COUNTRIES: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
12.6.3 REST OF MIDDLE EAST & AFRICA
TABLE 233 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 234 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT SOLUTIONS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 235 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET FOR SERVICES, BY TYPE, 2021–2028 (USD MILLION)
TABLE 236 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODALITY, 2021–2028 (USD MILLION)
TABLE 237 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY MODE OF DEPLOYMENT, 2021–2028 (USD MILLION)
TABLE 238 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY REVENUE MODEL, 2021–2028 (USD MILLION)
TABLE 239 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY APPLICATION, 2021–2028 (USD MILLION)
TABLE 240 REST OF MIDDLE EAST & AFRICA: RADIATION DOSE MANAGEMENT MARKET, BY END USER, 2021–2028 (USD MILLION)
13 COMPETITIVE LANDSCAPE
13.1 INTRODUCTION
13.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
TABLE 241 OVERVIEW OF STRATEGIES ADOPTED BY KEY PLAYERS IN RADIATION DOSE MANAGEMENT MARKET
13.3 REVENUE SHARE ANALYSIS
FIGURE 36 REVENUE SHARE ANALYSIS, 2018–2022
13.4 MARKET SHARE ANALYSIS
FIGURE 37 MARKET SHARE ANALYSIS, 2022
TABLE 242 DEGREE OF COMPETITION: RADIATION DOSE MANAGEMENT MARKET
FIGURE 38 RANKING OF KEY COMPANIES IN RADIATION DOSE MANAGEMENT MARKET, 2022
13.5 BRAND/SOFTWARE COMPARISON
FIGURE 39 TOP TRENDING BRANDS/SOFTWARE IN RADIATION DOSE MANAGEMENT MARKET
FIGURE 40 BRAND/SOFTWARE COMPARISON: RADIATION DOSE MANAGEMENT MARKET
13.5.1 BAYER AG.
13.5.2 GE HEALTHCARE
13.5.3 PACSHEALTH, LLC
13.5.4 VOLPARA HEALTH LIMITED
13.5.5 BRACCO
13.6 COMPANY VALUATION AND FINANCIAL METRICS
13.7 COMPANY EVALUATION MATRIX
13.7.1 STARS
13.7.2 EMERGING LEADERS
13.7.3 PERVASIVE PLAYERS
13.7.4 PARTICIPANTS
FIGURE 41 COMPANY EVALUATION MATRIX, 2022
13.7.5 COMPANY FOOTPRINT
TABLE 243 OVERALL FOOTPRINT
TABLE 244 PRODUCT & SERVICE FOOTPRINT
TABLE 245 MODALITY FOOTPRINT
TABLE 246 REGIONAL FOOTPRINT
13.8 START-UP/SME EVALUATION MATRIX
13.8.1 PROGRESSIVE COMPANIES
13.8.2 RESPONSIVE COMPANIES
13.8.3 DYNAMIC COMPANIES
13.8.4 STARTING BLOCKS
FIGURE 42 START-UP/SME EVALUATION MATRIX, 2022
13.8.5 COMPETITIVE BENCHMARKING
TABLE 247 DETAILED LIST OF KEY START-UPS/SMES
TABLE 248 COMPETITIVE BENCHMARKING OF KEY START-UPS/SMES
13.9 COMPETITIVE SCENARIO
13.9.1 PRODUCT LAUNCHES
TABLE 249 RADIATION DOSE MANAGEMENT MARKET: PRODUCT LAUNCHES, 2020–2023
13.9.2 DEALS
TABLE 250 RADIATION DOSE MANAGEMENT MARKET: DEALS, 2020–2023
14 COMPANY PROFILES
(Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1 KEY PLAYERS
14.1.1 BAYER AG
TABLE 251 BAYER AG: COMPANY OVERVIEW
FIGURE 43 BAYER AG: COMPANY SNAPSHOT (2022)
TABLE 252 BAYER AG: PRODUCT LAUNCHES
14.1.2 GE HEALTHCARE
TABLE 253 GE HEALTHCARE: COMPANY OVERVIEW
FIGURE 44 GE HEALTHCARE: COMPANY SNAPSHOT (2022)
14.1.3 KONINKLIJKE PHILIPS N.V.
TABLE 254 KONINKLIJKE PHILIPS N.V.: COMPANY OVERVIEW
FIGURE 45 KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)
14.1.4 SECTRA AB
TABLE 255 SECTRA AB: COMPANY OVERVIEW
FIGURE 46 SECTRA AB: COMPANY SNAPSHOT (2022)
14.1.5 AGFA-GEVAERT GROUP
TABLE 256 AGFA-GEVAERT GROUP: COMPANY OVERVIEW
FIGURE 47 AGFA-GEVAERT GROUP.: COMPANY SNAPSHOT (2022)
TABLE 257 AGFA-GEVAERT GROUP: OTHER DEVELOPMENTS
14.1.6 SIEMENS HEALTHCARE PRIVATE LIMITED
TABLE 258 SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY OVERVIEW
FIGURE 48 SIEMENS HEALTHCARE PRIVATE LIMITED: COMPANY SNAPSHOT (2022)
TABLE 259 SIEMENS HEALTHCARE PRIVATE LIMITED: PRODUCT LAUNCHES
14.1.7 CANON MEDICAL SYSTEMS CORPORATION
TABLE 260 CANON MEDICAL SYSTEMS CORPORATION: COMPANY OVERVIEW
FIGURE 49 CANON MEDICAL SYSTEMS CORPORATION: COMPANY SNAPSHOT (2022)
14.1.8 PACSHEALTH, LLC
TABLE 261 PACSHEALTH, LLC: COMPANY OVERVIEW
14.1.9 NOVARAD CORPORATION
TABLE 262 NOVARAD CORPORATION: COMPANY OVERVIEW
14.1.10 QAELUM N.V.
TABLE 263 QAELUM N.V.: COMPANY OVERVIEW
TABLE 264 QAELUM N.V.: DEALS
14.1.11 BRACCO
TABLE 265 BRACCO: COMPANY OVERVIEW
14.1.12 GUERBET
TABLE 266 GUERBET: COMPANY OVERVIEW
FIGURE 50 GUERBET: COMPANY SNAPSHOT (2022)
14.1.13 FUJIFILM HOLDINGS CORPORATION
TABLE 267 FUJIFILM HOLDINGS CORPORATION: COMPANY OVERVIEW
FIGURE 51 FUJIFILM HOLDINGS CORPORATION: COMPANY SNAPSHOT (2022)
TABLE 268 FUJIFILM HOLDINGS CORPORATION: DEALS
14.1.14 INFINITT HEALTHCARE CO., LTD.
TABLE 269 INFINITT HEALTHCARE CO., LTD.: COMPANY OVERVIEW
14.1.15 MEDSQUARE
TABLE 270 MEDSQUARE: COMPANY OVERVIEW
14.1.16 MEDIC VISION
TABLE 271 MEDIC VISION: COMPANY OVERVIEW
14.1.17 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.
TABLE 272 NANJING PERLOVE MEDICAL EQUIPMENT CO., LTD.: COMPANY OVERVIEW
14.1.18 VOLPARA HEALTH LIMITED.
TABLE 273 VOLPARA HEALTH LIMITED: COMPANY OVERVIEW
FIGURE 52 VOLPARA HEALTH LIMITED: COMPANY SNAPSHOT (2022)
TABLE 274 VOLPARA HEALTH LIMITED: DEALS
14.1.19 MIRION TECHNOLOGIES, INC.
TABLE 275 MIRION TECHNOLOGIES, INC.: COMPANY OVERVIEW
14.2 OTHER PLAYERS
14.2.1 IMALOGIX
14.2.2 LANDAUER
14.2.3 RAYSEARCH LABORATORIES
14.2.4 I-SOLUTIONS HEALTH GMBH
14.2.5 MEDIGRATION
14.2.6 TECNOLOGIE AVANZATE
*Details on Business Overview, Products/Services/Solutions Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
5 APPENDIX
15.1 DISCUSSION GUIDE
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
15.3 CUSTOMIZATION OPTIONS
15.4 RELATED REPORTS
15.5 AUTHOR DETAILS
